Efficacy and safety of everolimus and exemestane for metastatic breast cancer patients: a real-life experience of three Oncology Departments

被引：0
|
作者：
Meattini, I. [1 ]
Salvadori, B. [2 ]
Coltelli, L. [3 ]
Perna, M. [1 ]
Carta, G. A. [1 ]
Becherini, C. [1 ]
Grassi, R. [1 ]
Garlatti, P. [1 ]
Cappelli, S. [3 ]
Desideri, I. [1 ]
Vannini, A. [1 ]
Fontana, A. [2 ]
Landucci, E. [2 ]
Michelotti, A. [2 ]
Ricci, S. [2 ]
Allegrini, G. [3 ]
Falcone, A. [2 ]
Livi, L. [1 ]
机构：
[1] Univ Firenze, Azienda Osped Univ Careggi, Florence, Italy
[2] Univ Pisa, Azienda Osped Univ Pisana, Pisa, Italy
[3] Osped Felice Lotti, Pontedera, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C63
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The efficacy and safety analysis of the treatments of everolimus and exemestane combination in 101 metastatic breast cancer patients: Real-life experience from Turkey
    Bilici, A.
    Menekse, S.
    Akin, S.
    Degirmenci, M.
    Olmez, O. F.
    Avci, N.
    Sakalar, T.
    Tural, D.
    Kaplan, M. A.
    Tanriverdi, O.
    Bilgetekin, I.
    Uslu, R.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Efficacy and tolerability of Everolimus-Exemestane combination therapy in metastatic breast cancer patients: experience in Real Life
    Cocciolone, V.
    Cannita, K.
    Tessitore, A.
    Rinaldi, L.
    Irelli, A.
    Dal Mas, A.
    Calvisi, G.
    Bafile, A.
    Alesse, E.
    Ricevuto, E.
    Ficorella, C.
    ANNALS OF ONCOLOGY, 2015, 26 : 24 - 24
  • [3] Efficacy and safety of eribulin in patients with metastatic breast cancer at early and late application: Real-life experience.
    Manzyuk, Valentina
    Gorbunova, Vera
    Kovalenko, Elena
    Bolotina, Larisa V.
    Semiglazova, Tatiana
    Ponomarenko, Dmitry
    Zhilyaeva, Larisa
    Mukhametshina, Venera
    Karabina, Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] From clinical trials to clinical practice: Real-life outcome data of everolimus and exemestane in the treatment of patients with metastatic breast cancer
    Abdel-Razeq, Hikmat
    Sharaf, Baha'
    Abdulelah, Hazem
    Inserat, Bayan
    Al-Tell, Abdallah
    Salam, Mourad
    Bater, Rayan
    CANCER RESEARCH, 2021, 81 (04)
  • [5] Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience
    Assi, Tarek
    Kattan, Joseph
    El Rassy, Elie
    Tabchi, Samer
    Chebib, Ralph
    Moussa, Tania
    Hanna, Colette
    El Karak, Fadi
    Farhat, Fadi
    Ghosn, Marwan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (05) : 1112 - 1116
  • [6] EFFICACY AND SAFETY OF ERIBULIN IN PATIENTS WITH TRIPLE NEGATIVE METASTATIC BREAST CANCER: REAL LIFE EXPERIENCE
    Valentinova, Ludmila Manzyuk
    BREAST, 2017, 36 : S57 - S58
  • [7] Efficacy and safety of eribulin in patients with triple negative metastatic breast cancer: real life experience
    Manikhas, A.
    Gorbunova, V.
    Manzyuk, L.
    Kovalenko, E.
    Bolotina, L.
    Zhukova, L.
    Vladimirova, L.
    Kolyadina, I.
    Ponomarenko, D.
    Mukhametshina, G.
    BREAST, 2019, 44 : S61 - S62
  • [8] Evaluation of safety and activity of everolimus plus exemestane in metastatic breast cancer: a single institution experience
    Ferrarini, I.
    Bertolini, I.
    Fancelli, S.
    De Angelis, C.
    Fontana, A.
    Salvadori, B.
    Landucci, E.
    Michelotti, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 15 - 16
  • [9] Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study
    Bilici, Ahmet
    Uysal, Mukremin
    Menekse, Serkan
    Akin, Semih
    Yildiz, Fatih
    Turan, Merve
    Sezgin Goksu, Sema
    Beypinar, Ismail
    Sakalar, Teoman
    Degirmenci, Mustafa
    Erdem, Dilek
    Basaran, Gul
    Olmez, Omer Fatih
    Avci, Nilufer
    Tural, Deniz
    Sakin, Abdullah
    Turker, Sema
    Demir, Atakan
    Temiz, Suleyman
    Kaplan, Muhammed Ali
    Dogan, Mutlu
    Tanriverdi, Ozgur
    Bilgetekin, Irem
    Cinkir, Havva Yesil
    Acikgoz, Ozgur
    Paydas, Semra
    Uslu, Ruchan
    Turhal, Serdar
    CANCER INVESTIGATION, 2022, 40 (02) : 199 - 209
  • [10] Evaluation of safety and activity of everolimus plus exemestane in metastatic breast cancer: A single institution experience.
    Ferrarini, Ilaria
    Raoufi, Atefeh
    Bertolini, Ilaria
    Fancelli, Sara
    De Angelis, Carmine
    Diodati, Francesca
    Fontana, Andrea
    Salvadori, Barbara
    Landucci, Elisabetta
    Michelotti, Andrea
    Antonuzzo, Andrea
    Roncella, Silvio
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345